| Criteria |
---|---|
1 | Care dependency |
2 | Disability in lower extremities |
3 | Arthritis or arthrosis in knee or hip joints, arthritis requiring medication, or other rheumatic diseases potentially affecting joints or muscles |
4 | Diagnosed or suspected knee osteoarthritis (based on EULAR criteria: three symptoms and three signs); excluded if more than one of the following thee symptoms are found: morning stiffness <30Â minutes, persistent knee pain, or functional limitations |
5 | Bilateral knee alloplastic and hip alloplastic material |
6 | Connective tissue disorders |
7 | Severe COPD (FEV1/FVC ratio <70 % and FEV1 < 50 % of predicted value (GOLD stage 3 or 4) |
8 | Unstable cardiac arrhythmias or decreased LVEF (<60Â %) |
9 | Gut diseases affecting food absorption |
10 | Surgical diseases affecting ability to conduct heavy load strength exercise |
11 | Embodied magnetic metal |
12 | Endocrinological diseases potentially affecting muscles (diabetes mellitus, growth hormone-treated, sex hormone-treated, or untreated thyroid diseases) |
13 | Alcohol consumption >21 U/week for men and 14 U/week for women (1 U = 15.2 ml of alcohol) |
14 | Participation in studies using the same stable isotopically labeled tracers as this study (i.e., L-[ring-13C6]phenylalanine) within the last 6Â months |
15 | Medications: systemic corticosteroids, sex hormone therapy, anti-sex hormone therapy, anticoagulants (thrombin inhibitors, K-vitamin antagonists, heparins, pentasaccharides, factor Xa inhibitors, thrombocyte inhibitors except nonsteroidal anti-inflammatory drugs and acetylsalicylic acid). |
16 | >1Â h of weekly heavy strength training |
17 | Dementia or other severe cognitive impairment |
18 | Not holding Danish citizenship or not fluent in Danish |